Literature DB >> 21674249

Association of expression of kruppel-like factor 4 and kruppel-like factor 5 with the clinical manifestations of breast cancer.

Chih-Jung Chen1, Sey-En Lin, Yueh-Min Lin, Shu-Hui Lin, Dar-Ren Chen, Chi-Long Chen.   

Abstract

Kruppel-like factors (KLFs) are import modulators of cell proliferation, differentiation, and transformation and have recently been considered possible prognostic factors in breast cancer. In this study, we investigated the correlation between KLF4 and KLF5 expression and the clinical manifestations of breast cancer by immunohistochemical analysis. We observed increased KLF4 and KLF5 expression in tumor cells (invasive and in situ carcinomas), consistent KLF4 and KLF5 expression in in situ and invasive carcinomas, significant associations between KLF4 expression and tumor grade (p = 0.033), size (p = 0.035) and stage (p = 0.006), and an association between KLF5 expression and tumor grade (p = 0.033). Interestingly, we observed a relationship between increasing age and KLF4 expression (p = 0.007), with a tendency towards greater expression in tumor cells in patients over 50 years old. Moreover, KLF5 nuclear localization was restricted to non-tumor breast ducts and lobules; however, loss of nuclear expression of KLF5 in in situ and invasive carcinomas was observed. Although the mechanism of the loss of KLF5 nuclear expression is not clear, this phenomenon may imply a possible tumor-suppressor-like role for KLF5 in breast cancer tumorigenesis. The expression of KLF4 and KLF5 in breast cancer patients in Taiwan is similar to that in Western countries, except for the uncertainty surrounding its prognostic significance. Further clarification of the underlying mechanisms of KLF4 and KLF5 expression and their correlations with breast cancer outcomes is necessary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674249     DOI: 10.1007/s12253-011-9422-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  20 in total

Review 1.  Mammalian Krüppel-like transcription factors: more than just a pretty finger.

Authors:  J Turner; M Crossley
Journal:  Trends Biochem Sci       Date:  1999-06       Impact factor: 13.807

2.  Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer.

Authors:  Dan Tong; Klaus Czerwenka; Georg Heinze; Martin Ryffel; Eva Schuster; Armin Witt; Sepp Leodolter; Robert Zeillinger
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

3.  Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.

Authors:  Xianhui Wang; Mingzhe Zheng; Gang Liu; Weiya Xia; Paula J McKeown-Longo; Mien-Chie Hung; Jihe Zhao
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 4.  KLF4, p21 and context-dependent opposing forces in cancer.

Authors:  Benjamin D Rowland; Daniel S Peeper
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

5.  Increase of GKLF messenger RNA and protein expression during progression of breast cancer.

Authors:  K W Foster; A R Frost; P McKie-Bell; C Y Lin; J A Engler; W E Grizzle; J M Ruppert
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

6.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene.

Authors:  Benjamin D Rowland; René Bernards; Daniel S Peeper
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

7.  Unique features of breast cancer in Taiwan.

Authors:  S H Cheng; M H Tsou; M C Liu; J J Jian; J C Cheng; S Y Leu; C Y Hsieh; A T Huang
Journal:  Breast Cancer Res Treat       Date:  2000-10       Impact factor: 4.872

Review 8.  Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer.

Authors:  A R Black; J D Black; J Azizkhan-Clifford
Journal:  J Cell Physiol       Date:  2001-08       Impact factor: 6.384

9.  Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.

Authors:  Ceshi Chen; Xiaodong Sun; Peng Guo; Xue-Yuan Dong; Pooja Sethi; Xiaohong Cheng; Jun Zhou; Junxiu Ling; Jonathan W Simons; Jerry B Lingrel; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

Review 10.  Zinc fingers in Caenorhabditis elegans: finding families and probing pathways.

Authors:  N D Clarke; J M Berg
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

View more
  13 in total

Review 1.  MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer.

Authors:  Sriganesh B Sharma; John Michael Ruppert
Journal:  Drug Dev Res       Date:  2015-08-18       Impact factor: 4.360

2.  Role of Krüppel-like factor 4 and heat shock protein 27 in cancer of the larynx.

Authors:  Jihad Karam; Marie Claude Fadous-Khalifé; Rita Tannous; Sally Fakhreddine; Marcel Massoud; Joseph Hadchity; Georges Aftimos; Elie Hadchity
Journal:  Mol Clin Oncol       Date:  2017-09-19

3.  KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2.

Authors:  L Jia; Z Zhou; H Liang; J Wu; P Shi; F Li; Z Wang; C Wang; W Chen; H Zhang; Y Wang; R Liu; J Feng; C Chen
Journal:  Oncogene       Date:  2015-07-20       Impact factor: 9.867

4.  Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis.

Authors:  Dong Hu; Zhuan Zhou; Nancy E Davidson; Yi Huang; Yong Wan
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

5.  Association of Kruppel-like factor 4 expression with the prognosis of esophageal squamous cell carcinoma patients.

Authors:  Ming-Quan Ma; Hong-Dian Zhang; Peng Tang; Hong-Jing Jiang; Chuan-Gui Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 6.  Role of Krüppel-like factors in cancer stem cells.

Authors:  Yueling Zhang; Jin Hao; Yingcheng Zheng; Dian Jing; Yu Shen; Jun Wang; Zhihe Zhao
Journal:  J Physiol Biochem       Date:  2015-01-24       Impact factor: 4.158

7.  Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.

Authors:  Houjun Xia; Chunyan Wang; Wenlin Chen; Hailin Zhang; Leena Chaudhury; Zhongmei Zhou; Rong Liu; Ceshi Chen
Journal:  J Biol Chem       Date:  2013-08-02       Impact factor: 5.157

8.  MicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1.

Authors:  Sriganesh B Sharma; Chen-Chung Lin; Mark K Farrugia; Sarah L McLaughlin; Emily J Ellis; Kathleen M Brundage; Mohamad A Salkeni; J Michael Ruppert
Journal:  Mol Cell Biol       Date:  2014-09-08       Impact factor: 4.272

Review 9.  Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence.

Authors:  Mariana Segovia-Mendoza; María E González-González; David Barrera; Lorenza Díaz; Rocío García-Becerra
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

10.  Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer.

Authors:  M K Farrugia; S B Sharma; C-C Lin; S L McLaughlin; D B Vanderbilt; A G Ammer; M A Salkeni; P Stoilov; Y M Agazie; C J Creighton; J M Ruppert
Journal:  Cell Death Dis       Date:  2015-03-19       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.